241 related articles for article (PubMed ID: 26037161)
1. UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients.
De Nicolò A; Simiele M; Pensi D; Boglione L; Allegra S; Di Perri G; D'Avolio A
J Pharm Biomed Anal; 2015 Oct; 114():127-32. PubMed ID: 26037161
[TBL] [Abstract][Full Text] [Related]
2. UHPLC-MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients.
De Nicolò A; Avataneo V; Rabbia F; Bonifacio G; Cusato J; Tomasello C; Perlo E; Mulatero P; Veglio F; Di Perri G; D'Avolio A
J Pharm Biomed Anal; 2016 Sep; 129():535-541. PubMed ID: 27497654
[TBL] [Abstract][Full Text] [Related]
3. Rapid quantification of tenofovir in umbilical cord plasma and amniotic fluid in hepatitis B mono-infected pregnant women during labor by ultra-performance liquid chromatography/tandem mass spectrometry.
Ma Z; Li S; He D; Wang Y; Jiang H; Zhou H; Jin J; Lin N
Rapid Commun Mass Spectrom; 2020 May; 34(9):e8728. PubMed ID: 31960519
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of pradefovir, PMEA and tenofovir in HBV patient serum using liquid chromatography-tandem mass spectrometry and application to phase 2 clinical trial.
Xiao Q; Wang D; Yang W; Chen L; Ding Y; Yang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():133-140. PubMed ID: 27089519
[TBL] [Abstract][Full Text] [Related]
5. UHPLC-MS/MS method with automated on-line solid phase extraction for the quantification of entecavir in peripheral blood mononuclear cells of HBV+ patients.
De Nicolò A; Bonifacio G; Boglione L; Cusato J; Pensi D; Tomasello C; Di Perri G; D'Avolio A
J Pharm Biomed Anal; 2016 Jan; 118():64-69. PubMed ID: 26517850
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D.
Boglione L; D'Avolio A; Cariti G; Gregori G; Burdino E; Baietto L; Cusato J; Ghisetti V; De Rosa FG; Di Perri G
Liver Int; 2013 Apr; 33(4):580-5. PubMed ID: 23311449
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
8. A novel LC-MS/MS method for simultaneous quantification of tenofovir and lamivudine in human plasma and its application to a pharmacokinetic study.
Matta MK; Burugula L; Pilli NR; Inamadugu JK; J V L N SR
Biomed Chromatogr; 2012 Oct; 26(10):1202-9. PubMed ID: 22222724
[TBL] [Abstract][Full Text] [Related]
9. A review of entecavir in the treatment of chronic hepatitis B infection.
Rivkin A
Curr Med Res Opin; 2005 Nov; 21(11):1845-56. PubMed ID: 16307706
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a rapid ultra high performance liquid chromatography with tandem mass spectrometry method for the simultaneous determination of darunavir, ritonavir, and tenofovir in human plasma: Application to human pharmacokinetics.
Reddy AV; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J; Madhavi G
J Sep Sci; 2015 Aug; 38(15):2580-7. PubMed ID: 25989063
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of nucleos(t)ide analogues in chronic hepatitis B patients undergoing cytotoxic chemotherapy.
Tseng CM; Chen TB; Hsu YC; Chang CY; Lin JT; Mo LR
Asia Pac J Clin Oncol; 2016 Dec; 12(4):421-429. PubMed ID: 27435683
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the antiviral effects of different nucleos(t)ide analogues in chinese patients with chronic hepatitis B: a head-to-head study.
Yu S; Zhou Q; Zhao XM; Yuan M; Wang CT; Cheng XG; Zhang ZH; Li X
Saudi J Gastroenterol; 2014; 20(6):350-5. PubMed ID: 25434315
[TBL] [Abstract][Full Text] [Related]
13. A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir.
D'Avolio A; De Nicolò A; Agnesod D; Simiele M; Mohamed Abdi A; Dilly Penchala S; Boglione L; Cariti G; Di Perri G
J Pharm Biomed Anal; 2013 May; 78-79():217-23. PubMed ID: 23501442
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of an assay for the simultaneous determination of zidovudine, abacavir, emtricitabine, lamivudine, tenofovir and ribavirin in human plasma using liquid chromatography-tandem mass spectrometry.
Kromdijk W; Pereira SA; Rosing H; Mulder JW; Beijnen JH; Huitema AD
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 919-920():43-51. PubMed ID: 23411018
[TBL] [Abstract][Full Text] [Related]
15. Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC-MS/MS.
Waitt C; Diliiy Penchala S; Olagunju A; Amara A; Else L; Lamorde M; Khoo S
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():300-307. PubMed ID: 28651173
[TBL] [Abstract][Full Text] [Related]
16. Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection.
Mallet V; Schwarzinger M; Vallet-Pichard A; Fontaine H; Corouge M; Sogni P; Pol S
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1181-8.e1. PubMed ID: 25460550
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis.
Köklü S; Tuna Y; Gülşen MT; Demir M; Köksal AŞ; Koçkar MC; Aygün C; Coban S; Ozdil K; Ataseven H; Akin E; Pürnak T; Yüksel I; Ataseven H; Ibiş M; Yildirim B; Nadir I; Küçükazman M; Akbal E; Yüksel O; Başar O; Alkan E; Baykal O
Clin Gastroenterol Hepatol; 2013 Jan; 11(1):88-94. PubMed ID: 23063679
[TBL] [Abstract][Full Text] [Related]
18. Monotherapy for hepatitis B infection: a review of treatment options.
Ozaras R; Khodor H; Yetim N; Unal UK; Demirhan YE; Gultekin G; Isal B
Expert Rev Anti Infect Ther; 2015; 13(12):1457-68. PubMed ID: 26414781
[TBL] [Abstract][Full Text] [Related]
19. Quantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometry.
Le Saux T; Chhun S; Rey E; Launay O; Weiss L; Viard JP; Pons G; Jullien V
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Apr; 865(1-2):81-90. PubMed ID: 18325857
[TBL] [Abstract][Full Text] [Related]
20. Antiviral effect of entecavir in nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy.
Chen CH; Hu TH; Hung CH; Wang JH; Lu SN; Lee CM
J Viral Hepat; 2014 Aug; 21(8):e55-64. PubMed ID: 24766327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]